Rebirth: Super Banking System Chapter 2381 - 2221: An Official Document
Previously on Rebirth: Super Banking System...
A truly bold action!
Yet.
Tang Qing stayed composed. One hundred twenty billion RMB doesn't amount to much. Moreover, this marks only the start. Remember, the global market awaits.
Take Myanmar, for instance.
The contracts there will match this scale or more.
Military uniforms.
Protective gear.
Cleaning outfits.
Uniforms for workers.
...
Via government channels, widespread rollout across Myanmar will occur, similar to how the Myanmar Bank Group outfits its over one million staff.
That's an enormous figure.
Furthermore.
Thanks to worldwide deals secured by the team and listing in the commodity financing list, combined with everyday consumer needs, demand will surge dramatically.
Annual revenue topping a hundred billion? That's no big deal.
Without doubt.
Major apparel firms from Europe and America are reaching out for partnerships; we supply the fabrics, they handle the talks, enabling militaries and law enforcement in those nations to buy in.
Win-win for everyone.
On this front.
Tang Qing welcomes it warmly, sparing his team the extra effort!
...
After two days.
In Beijing.
An announcement dropped abruptly, packed with details but boiling down to key points:
"Starting now, Myanmar Pharmaceutical Group's Alzheimer's treatment meds can enter the Huaxia market, with initial trials at select Beijing hospitals."
"The trial lasts two months."
"Post-trial, if results prove effective, nationwide rollout follows, and Alzheimer's coverage under medical insurance kicks in from April 1st."
Right after it went live.
Boom.
It shot straight to the top of trending topics.
First look.
Folks lit up with joy.
"Awesome, months of waiting, and now light at the end of the tunnel."
"Thrilled!"
"Lifeline for the worst cases."
"..."
Across the country.
Support groups and forums buzzed with shares, excitement everywhere, particularly among families of advanced sufferers, since few could afford trips to Myanmar.
The trip's too distant.
Flights.
Out of reach.
Boats.
Worse still.
Land routes are the norm, but they're grueling, too harsh for fragile patients, and mishaps could spell disaster!
Hence.
Everyone anticipated this eagerly.
Today.
Hope shines bright.
Sure, Beijing's not close, but word is, after two months of success, it'll spread everywhere, no long journeys required.
Thus.
Out-of-towners must hold on for another two months max. If patients stay stable till then, recovery's just around the corner—pure bliss.
Soon after.
The Health Ministry site crashed under traffic spikes, as relatives rushed to book, and trial hospitals prepped rooms for critical arrivals.
Mild cases.
Moderate ones.
No inpatient stays needed for these.
So.
Slots abound for bookings, unlike Myanmar's city housing caps that limited totals, but Beijing's capacity dwarfs that.
Plus.
Airbnbs.
Apartments for lease.
Family stays.
...
Everything tapped, outstripping Yangon's new district by miles, able to handle a staggering patient load—the bottleneck's just Myanmar's med supply.
Luckily.
No sweat there; stockpiles built during trials are massive, more than enough for Huaxia's needs.
...
Beijing.
Inside a lab facility.
"Excellent."
"Excellent."
"..."
On the med approval, Shi Ze kept praising it, a boon as a sufferer himself, and a thrill as a researcher.
Now, countless souls can break free from disease's grip and start anew.
Still.
Pondering the drug costs, his expression flickered.
Costly?
Hardly.
Per-person expense isn't steep at all. But scaled up, the tally's hefty—the initial import batch hits 60 billion RMB.
Wow!
Sixty.
Billion!
Far from pocket change; in 2010, that's a fortune.
Breakdown.
This stock treats roughly one point five million folks, at thirty to forty thousand per course, minus insurance payouts.
Out-of-pocket? Just one or two thousand RMB tops.
Nice!
Fair pricing!
Against those bloodsucking Western pharma giants, this screams integrity. Were they in possession of this tech?
Ten grand.
Might cover basics only.
Twenty grand.
For mid-level.
Hundred grand.
End-stage care.
No hype—those firms lobby to offload costs onto governments, raking in piles.
Thus.
Shi Ze sees no gripe with the rate; gratitude's in order.
...
That very day.
Beijing.
Lodgings by trial sites filled up fast, rentals too amid the month-long therapy and monitoring.
Naturally.
Renting beats hotel bills hands down for savings.
So.
Demand up, prices climb, but not wildly—plenty aren't big spenders. Mild and moderate patients stay mobile.
On foot.
Farther spots? Cabs work fine, much like chemo routines needing daily check-ins, while critical ones occupy hospital wards.
Before.
Beds stayed packed, referrals bringing distant crowds.
Today.
Total shift.
Tumors.
Blood cancers.
Tons of ops skip overnight stays; uniform care standards nationwide spread the load, leaving entire levels vacant.
A rare phenomenon, unseen in ages.
...
Overseas press.
Right now.
Humming too.
America.
"How soon till we get it? Dad's bedbound in care for three years, can't move to Myanmar—without help, he's done."
"Ditto."
"Demand it now, fast-track entry."
"Agreed."
"..."
Families of sufferers raised a racket.
Earlier.
Cancer? Fly to Myanmar despite no local fluid treatments. But this? Impossible.
Untreated.
Straight to the grave—in recent months, over a thousand terminal Alzheimer's cases perished stateside, sparking family uproars.
After all.
Loved ones could've endured, maybe shared meals, talks, old tales, yet vanished.
So.
Heartbreaking beyond words.
"Boycott!"
"Roll it out by next week, or deaths mount."
"Bring it in!"
"Bring it in!"
"..."
Protests erupted in city centers; White House lawns in D.C. drew big crowds, united on one demand.
---Approve the Alzheimer's cure.
Or.
Charter flights for transport to care; aid groups joined, yelling that immobile folks' rights matter.
Quite the spectacle.
...
Across Europe.
Identical uproar, same grievances; early and mid-stages can hold, but terminals have scant time.
Months on.
Plenty to bury thousands.